Aspirin reduces risk of colorectal cancer incidence, mortality

December 2010
Formulary;Dec2010, Vol. 45 Issue 11, p341
Academic Journal
The article discusses research showing that aspirin reduces the risk of colorectal cancer incidence and mortality. The research team conducted an independent patient data meta-analysis, following 14,000 patients for approximately 20 years of follow-up as part of five pooled randomized trials. Statistics related to the trial results are presented.


Related Articles

  • New study supports benefits of aspirin for colorectal cancer prevention.  // Gastrointestinal Nursing;Dec2010, Vol. 8 Issue 10, p12 

    The article reports on the findings of a study conducted by Peter Rothwell of the University of Oxford and his colleagues regarding the potential benefits of aspirin to prevent colorectal cancer. It cites that regular intake of aspirin may save thousands of patients with proximal colon cancers....

  • Low-Dose Aspirin May Reduce Long-Term Risk of Colorectal Cancer. McBride, Deborah // ONS Connect;Apr2011, Vol. 26 Issue 4, p6 

    The article focuses on a research study according to which long-term daily use of low-dose aspirin, of at least 75 milligram (mg)reduces the long-term risk of colorectal cancer and deaths.

  • Aspirin a day could keep cancer away.  // Lamp;Oct2014, Vol. 71 Issue 9, p8 

    The article highlights the findings of a 2014 study on the benefits of taking aspirin daily to lowering the chances of getting common cancers, published in the journal "Annals of Oncology."

  • USING ASPIRIN TO PREVENT COLORECTAL CANCER: AN EVIDENCE BASED PRACTICE. Alnabali, Haneyah // Middle East Journal of Nursing;Jun2014, Vol. 8 Issue 3, p12 

    Colorectal cancer is a major public health concern, globally and nationally. Thus, every effort should be done to improve prevention strategies, which may decrease colorectal cancer incidence, and thus, decrease the number of people who suffer from this disease and its complications. Promising...

  • Aspirin reverses obesity cancer risk.  // Oncology Nurse Advisor;Sep/Oct2015, Vol. 6 Issue 5, p13 

    No abstract available.

  • Bowel screening programmes introduced in Republic of Ireland, Estonia and Jersey.  // Gastrointestinal Nursing;Feb2013, Vol. 11 Issue 1, p6 

    The article reports that the Republic of Ireland, Estonia, and Jersey in the Channel Islands have launched the much needed national bowel screening programme.

  • Clinical digest. Low-dose aspirin taken for at least 3.5 years may prevent colorectal cancer.  // Nursing Standard;8/7/2013, Vol. 27 Issue 49, p14 

    The article discusses research which was reported in the article "The Association Between Low-Dose Aspirin Use and the Incidence of Colorectal Cancer; A Nationwide Cohort Study" by W. Huang which was reported in "Alimentary Pharmacology & Therapeutics" and found that low dose aspirin taken for...

  • Lower doses of resveratrol are more effective at reducing colorectal cancer growth.  // Oncology Nurse Advisor;Sep/Oct2015, Vol. 6 Issue 5, p13 

    No abstract available.

  • Aspirin can lower bowel cancer risk.  // Independent Nurse;9/20/2010, p6 

    No abstract available.

  • journal scan.  // Gastrointestinal Nursing;Nov2010, Vol. 8 Issue 9, p15 

    The article focuses on the findings of studies related to nursing care. Researchers from California were able to collect and present 50 stool samples of micro-organisms using gene sequencing. Scottish scientists have found that aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) can...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics